Biogen: Neuralgia trials

The registry lists 13 Neuralgia studies with Biogen as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 5Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• 802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal NeuralgiaWithdrawnNCT03637387Phase 3
• 802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal NeuralgiaWithdrawnNCT03070132Phase 3
• Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074TerminatedNCT02957617Phase 2
• New Formulation and Food Effect Study of BIIB074CompletedNCT02951221Phase 1
• Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral RadiculopathyCompletedNCT02935608Phase 2
• PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian ParticipantsCompletedNCT02831517Phase 1
• Absorption, Metabolism, and Excretion Study of BIIB074CompletedNCT02751905Phase 1
• Effect of Itraconazole on the Pharmacokinetics of BIIB074CompletedNCT02698267Phase 1
• PK & Tolerability of CNV1014802 in Young and Elderly Healthy VolunteersCompletedNCT02359344Phase 1
• Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic NeuralgiaCompletedNCT01848730Phase 2
• Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral RadiculopathyCompletedNCT01561027Phase 2
• A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal NeuralgiaCompletedNCT01540630Phase 2
• Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy SubjectsTerminatedNCT00964288Phase 1